| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.31 | 0.09 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.2 | 0.2 |